Bases Moleculares de la Arteriosclerosis
CTS347
![Foto de Bases Moleculares de la Arteriosclerosis](/img/uploaded/ED68AE035A29D412AA3C2FBFA433060F.png)
![Foto de Hospital General Universitario Gregorio Marañón](/img/noimage_org.png)
Hospital General Universitario Gregorio Marañón
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital General Universitario Gregorio Marañón (11)
2018
-
Dilated Cardiomyopathy Due to BLC2-Associated Athanogene 3 (BAG3) Mutations
Journal of the American College of Cardiology, Vol. 72, Núm. 20, pp. 2471-2481
-
Echocardioscopy learning curve. Usefulness of an inter-speciality training program
Educacion Medica, Vol. 19, Núm. 2, pp. 91-95
2015
-
Efficacy and safety of rivaroxaban in real-life patients with atrial fibrillation
Expert Review of Cardiovascular Therapy, Vol. 13, Núm. 4, pp. 341-353
-
Relationship between lipoprotein (a) and micro/macro complications In type 2 diabetes mellitus: A forgotten target
Journal of Geriatric Cardiology, Vol. 12, Núm. 2, pp. 93-99
-
Sindrome metabólico en pacientes con fenotipo clínico de “cintura hipertrigliceridémica”
Nutricion Hospitalaria, Vol. 32, Núm. 3, pp. 1145-1152
2012
-
Perfil lipídico residual en la cardiopatía isquémica recurrente
Medicina Clinica, Vol. 138, Núm. 6, pp. 238-241
2011
-
Prevalencia del síndrome metabólico y de sus componentes en pacientes con síndrome coronario agudo
Revista Espanola de Cardiologia, Vol. 64, Núm. 7, pp. 579-586
2010
-
A very high prevalence of low HDL cholesterol in Spanish patients with acute coronary syndromes
Clinical Cardiology, Vol. 33, Núm. 7, pp. 418-423
2009
-
Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention
Vascular Health and Risk Management
2007
-
Management of dyslipidemia in the metabolic syndrome: Recommendations of the Spanish HDL-forum
American Journal of Cardiovascular Drugs, Vol. 7, Núm. 1, pp. 39-58
2004
-
Significance of high density lipoprotein-cholesterol in cardiovascular risk prevention: Recommendations of HDL Forum
American Journal of Cardiovascular Drugs, Vol. 4, Núm. 5, pp. 299-314